Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Cleveland center to provide lung cancer screening CT

Following the National Cancer Institutes (NCI) findings of the large-scale efficacy of lung cancer screening with CT, the newly opened University Hospital Seidman Cancer Center in Cleveland said it will offer CT screening to smokers with physician referrals.

AngioDynamics' CEO steps down after poor Q4 returns

Jan Keltjens has resigned as AngioDynamics' president, CEO and a member of its board of directors, and the company has already launched a search for his replacement.

Study: Cetuximab + chemoradiotherapy improves lung cancer treatment

Cetuximab combined with chemoradiotherapy increases lung cancer survival while inducing side effects comparable to chemotherapy alone, offering promising phase II results that clinicians hope will roll over to an ongoing phase III trial.

Pathology testing device may improve bedside cancer diagnosis

Scientists at Harvard Medical School may be close to perfecting a device that can allow oncologists to diagnose cancer at a patients bedside in less than 60 minutes, according to an article published in Technology Review.

IASLC releases lung cancer staging app for smartphones

The International Association for the Study of Lung Cancer (IASLC) has begun marketing a thoracic cancer staging application for mobile devices, including the iPhone, BlackBerry, Android and iPad.

JAMA: Diverting ambulances from EDs linked with increased death for MI patients

Among Medicare patients who experienced a heart attack in four California counties, when the nearest nearest emergency department (ED) diverts ambulance traffic for 12 hours or more, it was associated with an increased risk of death for up to one year, according to a study in the June 15 issue of Journal of the American Medical Association, which was released early online to coincide with its presentation at the AcademyHealth annual meeting in Seattle.

Study: Adjuvant radiotherapy effective, cost-effective for prostate cancer

Adjuvant radiation therapy administered early after radical prostatectomy is more effective than observation, at a mean additional cost of $6,023, resulting in a 10-year incremental cost-effectiveness ratio of $26,983, according to a study published June 9 in the Annals of Oncology.

FDA working to establish nanotechnology guidelines

The FDA has released a draft correspondence establishing a framework for the regulation and oversight of nanotechnology. Made available on its website on June 9, the document is a collaborative product between the National Economic Council, the Office of Management and Budget, the Office of Science and Technology Policy and the Office of the U.S. Trade Representative.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.